Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin)

1995 ◽  
Vol 95 (5) ◽  
pp. 962-969 ◽  
Author(s):  
C EBNER ◽  
R HIRSCHWEHR ◽  
L BAUER ◽  
H BREITENEDER ◽  
R VALENTA ◽  
...  
1996 ◽  
Vol 96 (3) ◽  
pp. 433-438 ◽  
Author(s):  
Ines Swoboda ◽  
Karin Hoffmann-Sommergruber ◽  
Gabriel O'Riordain ◽  
Otto Scheiner ◽  
Erwin Heberle-Bors ◽  
...  

1996 ◽  
Vol 96 (3) ◽  
pp. 433-438 ◽  
Author(s):  
Ines Swoboda ◽  
Karin Hoffmann-Sommergruber ◽  
Gabriel O'Riordain ◽  
Otto Scheiner ◽  
Erwin Heberle-Bors ◽  
...  

1996 ◽  
Vol 98 (5) ◽  
pp. 913-921 ◽  
Author(s):  
Susanne Vrtala ◽  
Peter Mayer ◽  
Fatima Ferreira ◽  
Markus Susani ◽  
Alec H. Sehon ◽  
...  

1996 ◽  
Vol 97 (1) ◽  
pp. 95-103 ◽  
Author(s):  
Fatima D. Ferreira ◽  
Peter Mayer ◽  
Wolfgang R. Sperr ◽  
Peter Valent ◽  
Susanne Seiberler ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Sheriene Moussa Afify ◽  
Isabella Pali-Schöll ◽  
Karin Hufnagl ◽  
Gerlinde Hofstetter ◽  
Maha Abdel-Rafea El-Bassuoni ◽  
...  

The lipocalin beta-lactoglobulin (BLG) is a major protein compound in cow’s milk, and we detected it in cattle stable dust. BLG may be a novel player in the farm protective effect against atopic sensitization and hayfever. In previous studies, we demonstrated that only the ligand-filled holo-form of BLG prevented sensitization to itself. Here, we investigated whether holo-BLG could, in an innate manner, also protect against allergic sensitization to unrelated birch pollen allergens using a murine model. BALB/c mice were nasally pretreated four times in biweekly intervals with holo-BLG containing quercetin–iron complexes as ligands, with empty apo-BLG, or were sham-treated. Subsequently, mice were intraperitoneally sensitized two times with apo-BLG or with the unrelated birch pollen allergen apo-Bet v 1, adjuvanted with aluminum hydroxide. After subsequent systemic challenge with BLG or Bet v 1, body temperature drop was monitored by anaphylaxis imaging. Specific antibodies in serum and cytokines of BLG- and Bet v 1-stimulated splenocytes were analyzed by ELISA. Additionally, human peripheral blood mononuclear cells of pollen allergic subjects were stimulated with apo- versus holo-BLG before assessment by FACS. Prophylactic treatment with the holo-BLG resulted in protection against allergic sensitization and clinical reactivity also to Bet v 1 in an unspecific manner. Pretreatment with holo-BLG resulted in significantly lower BLG-as well as Bet v 1-specific antibodies and impaired antigen-presentation with significantly lower numbers of CD11c+MHCII+ cells expressing CD86. Pretreatment with holo-BLG also reduced the release of Th2-associated cytokines from Splenocytes in BLG-sensitized mice. Similarly, in vitro stimulation of PBMCs from birch pollen allergic subjects with holo-BLG resulted in a relative decrease of CD3+CD4+ and CD4+CRTh2 cells, but not of CD4+CD25+CD127− Treg cells, compared to apo-BLG stimulation. In conclusion, prophylactic treatment with holo-BLG protected against allergy in an antigen-specific and -unspecific manner by decreasing antigen presentation, specific antibody production and abrogating a Th2-response. Holo-BLG therefore promotes immune resilience against pollen allergens in an innate manner and may thereby contribute to the farm protective effect against atopic sensitization.


Allergy ◽  
2021 ◽  
Author(s):  
Karin Hufnagl ◽  
Livia Kromp ◽  
Rodolfo Bianchini ◽  
Sheriene Moussa Afify ◽  
Markus Wiederstein ◽  
...  
Keyword(s):  

1997 ◽  
Vol 114 (3) ◽  
pp. 272-277 ◽  
Author(s):  
D. Dormann ◽  
E. Montermann ◽  
L. Klimek ◽  
B. Weber ◽  
C. Ebner ◽  
...  

2009 ◽  
Vol 124 (1) ◽  
pp. 135-142.e21 ◽  
Author(s):  
Sakari Joenväärä ◽  
Pirkko Mattila ◽  
Jutta Renkonen ◽  
Antti Mäkitie ◽  
Sanna Toppila-Salmi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document